Tag: microrna market growth

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theMicroRNA Market?

The surge in cancer incidences is anticipated to significantly boost the microRNA market’s expansion in the future. Cancer constitutes a complicated illness typified by rampant cell growth and proliferation, sometimes resulting in the creation of malignant tumors that can intrude on surrounding tissues and metastasize to far-off organs, thus posing considerable health threats. The uptick in cancer incidences can be attributed to various elements, such as aging demographics, lifestyle decisions like smoking and poor nutrition, environmental toxins, and advanced detection techniques resulting in early diagnosis. MicroRNA is amalgamated with standard cancer treatments to augment drug sensitivity and enhance the final results. Beyond the realm of treatment, miRNAs function as diagnostic and prognostic biomarkers, assisting in classifying different cancer types, forecasting the progression of the disease and tracking treatment responses. For example, as per the National Cancer Institute, a government agency based in the United States, in May 2024, approximately 20 million fresh cases and 9.7 million cancer-related fatalities were annually documented in 2022, and forecasts suggest that by 2040, the figures would escalate to 15.3 million deaths and 29.9 million fresh cases annually. Consequently, the surge in cancer incidences is stimulating the expansion of the microRNA market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15608&type=smp

#What Are the Key Projections for the CAGR of the MicroRNA Market From 2025 to 2034?

The size of the microrna market has seen substantial expansion lately. The market is set to enlarge from $1.33 billion in 2024 to $1.58 billion in 2025, illustrating a compound annual growth rate (CAGR) of 18.9%. This substantial increase during the historic period is primarily due to the inception of microRNAs, RNA interference (RNAi), various genome sequencing initiatives, advances in computational biology and bioinformatics, and an in-depth research on extracellular vehicles (EVs).

Predictions indicate swift expansion for the microrna market in the upcoming years. Its valuation is projected to reach $3.11 billion in 2029, with a compound annual growth rate (CAGR) of 18.5%. The predicted growth within the forecast period can be credited to aspects like clinical translation, regulatory networks, systems biology, microRNA-centric treatments, potential therapeutic applications, and the identification of biomarkers. Top trends projected to dominate during the forecast period include technological progression, bioinformatics, data analysis, conservation across various species, interactions with microbiomes, and operational mechanisms.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15608

What Key Market Trends and Innovations Are Shaping the Future of theMicroRNA Industry?

Key players in the microRNA market are prioritizing the development of innovative solutions such as MiRNA probe customization services with the aim to cater to the particular requirements of researchers and clinicians, improve the precision of miRNA detection, and support a plethora of applications. This refers to unique services provided by biotechnology and molecular biology firms to create and prepare customized probes that correspond to specific microRNAs (miRNAs) for a variety of research and clinical uses. In September 2023, for example, Abnova Corporation, a biotech company based in Taiwan, introduced enhanced miRNA probe customization services, and a fresh series of cataloged miRNA probes, aiming to fulfill the varying requirements of academic, industrial, and miRNA research communities. These probes are critical in recognizing and accurately pinpointing miRNAs, small non-coding RNA molecules that are integral to numerous biological processes. The customization services offered by Abnova guarantee maximum specificity and minimal cross-reactivity, rendering them ideal for the analysis of samples with scarce miRNA content.

Which Companies Are Leading the Charge in Expanding theMicroRNA Market Growth?

Major companies operating in the MicroRNA market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Kaneka Corporation, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Biodynamics Laboratory Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Biogenex Laboratories, Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc., Synlogic Inc., Sistemic Scotland Limited

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/microrna-global-market-report

How is the Global MicroRNA Market Segemented?

The microrna market covered in this report is segmented –

1) By Products: Instruments, Consumables

2) By Assay Type: Immunoassay, Next Generation Sequencing, miRNA Arrays, Polymerase Chain Reaction (PCR) Based Arrays

3) By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications

4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Clinical Research Organizations

Subsegments:

1) By Instruments: Qpcr Systems (Quantitative Pcr), Microarray Platforms, Next-Generation Sequencing (Ngs) Systems, Real-Time Pcr Instruments, Microrna Analyzers

2) By Consumables: Microrna Kits ( Extraction Kits, Detection Kits), Pcr Reagents, Primers And Probes, Microarrays And Chips, Rna Sequencing Kits

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15608&type=smp

Which Geographics are Influencing the Growth of the MicroRNA Market?

North America was the largest region in the microRNA market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the MicroRNA market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global MicroRNA Market 2025, By The Business Research Company:

Physical Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/physical-therapy-global-market-report

Mycoplasma Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Antiphospholipid Syndrome Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antiphospholipid-syndrome-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Discover trends, market shifts, and competitive outlooks for the microrna industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Key Projections for the CAGR of the MicroRNA Market Size From 2025 to 2034?

The market size of microrna has seen significant expansion in the past few years. The market is projected to inflate from $1.33 billion in 2024 to $1.58 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 18.9%. The substantial growth during the historical period is ascribed to factors such as the discovery of microRNAs, RNA interference (RNAi), genome sequencing projects, research in computational biology and bioinformatics, and studies on extracellular vehicles (EVs).

In the coming years, there’s a forecast of swift expansion in the microrna market size, projected to hit $3.11 billion by 2029, boasting a compound annual growth rate (CAGR) of 18.5%. Key factors contributing to this growth during the forecasted period include clinical translation, regulatory systems and networks, microRNA-centered therapies, therapeutic potential, and discovery of biomarkers. Significant trends projected during the forecasted period include advancements in technology, bioinformatics and data interpretation, cross-species conservation, microbe interactions, and functional mechanisms.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15608&type=smp

What Are the Core Market Drivers Propelling Growth in the MicroRNA Industry?

The rise in cancer instances is projected to fuel the expansion of the microRNA market. Characterized by uncontrolled growth and proliferation of cells, cancer often results in malignant tumors that can infiltrate nearby tissues and metastasize to far-off organs, leading to considerable health threats. An aging populace, lifestyle preferences such as smoking and a lackluster diet, environmental toxins, and better detection techniques resulting in earlier diagnoses, all fuel the increasing prevalence of cancer. Conventional cancer treatments are augmented with microRNA to enhance drug receptivity and boost results. Moreover, miRNAs function as diagnostic and prognostic biomarkers, aiding in demarcating cancer varieties, projecting disease development, and tracking treatment reactions. To illustrate, the US’s National Cancer Institute reported approximately 20 million new cases and 9.7 million cancer-related fatalities annually in 2022, as of May 2024. Forecasts also suggest around 15.3 million deaths and 29.9 million novel instances per annum by 2040. Consequently, the escalating count of cancer instances serves as a key driver for the microRNA market’s growth.

What Segment Types Define the MicroRNA Market Structure?

The microrna market covered in this report is segmented –

1) By Products: Instruments, Consumables

2) By Assay Type: Immunoassay, Next Generation Sequencing, miRNA Arrays, Polymerase Chain Reaction (PCR) Based Arrays

3) By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications

4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Clinical Research Organizations

Subsegments:

1) By Instruments: Qpcr Systems (Quantitative Pcr), Microarray Platforms, Next-Generation Sequencing (Ngs) Systems, Real-Time Pcr Instruments, Microrna Analyzers

2) By Consumables: Microrna Kits ( Extraction Kits, Detection Kits), Pcr Reagents, Primers And Probes, Microarrays And Chips, Rna Sequencing Kits

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15608&type=smp

Which Regions Are Driving the Next Phase of the MicroRNA Market Growth?

North America was the largest region in the microRNA market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the MicroRNA market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in the MicroRNA Market Over the Coming Years?

Top companies in the microRNA marketplace are majorly focusing their efforts on the development of sophisticated solutions like MiRNA probe personalization services. Such services are crucial to cater to the unique requirements of researchers and clinicians, to boost MiRNA detection accuracy and to support a broad spectrum of applications. The provision of MiRNA probe personalization services entails specialized services by biotech and molecular biology firms to create and deliver customized probes exclusive to certain microRNAs (miRNAs) for diverse research and clinical uses. For example, in September 2023, Taiwanese biotech firm Abnova Corporation rolled out enhanced services for personalizing miRNA probes. Alongside, the company also unveiled a fresh line of cataloged miRNA probes to fulfill the varied needs of academic, industrial, and research bodies undertaking miRNA study. These probes are instrumental in discovering and accurately pinpointing miRNAs, small non-coding RNA molecules critical for multiple biological functions. Abnova’s probe personalization services guarantee high specificity with minimal cross-reactivity, making them appropriate for examining limited miRNA content samples.

View the full report here:

https://www.thebusinessresearchcompany.com/report/microrna-global-market-report

What Is the Definition of the MicroRNA Market?

MicroRNAs are small, non-coding RNA molecules, typically about 20-22 nucleotides in length, used to regulate gene expression. They function by binding to complementary sequences on messenger RNA (mRNA) molecules, usually resulting in gene silencing through translational repression or target degradation.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15608

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the microrna market right now?

The scale of the microrna market has seen a significant increase recently, with projections showing it expanding from $1.33 billion in 2024 to $1.58 billion in 2025, maintaining a compound annual growth rate (CAGR) of 18.9%. The growth witnessed in the past years can be traced back to factors such as the discovery of microRNAs, RNA interference (RNAi), genome sequencing efforts, the rise of computational biology and bioinformatics, and research into extracellular vehicles (EVs).

How fast Is the microrna market expected to grow, and what’s its future value?

In the forthcoming years, the microrna market is projected to experience an accelerated growth, reaching $3.11 billion in 2029 with a compound annual growth rate (CAGR) of 18.5%. Clinical translation, regulatory networks, systems biology, microRNA-centered therapeutics, potential therapies, and discovery of biomarkers are factors propelling the growth in this forecast phase. The key trends during this period are likely to involve technological enhancements, bioinformatics, data interpretation, conservation across species, interactions within the microbiome, and operative mechanisms.

Get your microrna market report here!

https://www.thebusinessresearchcompany.com/report/microrna-global-market-report

What are the leading drivers of growth in the microrna market?

The growth of the microRNA market is being fuelled by the rise in cancer incidences. Cancer is a multifaceted disease that is characterized by the unregulated growth and proliferation of cells, which often results in the creation of malignant tumors that can infest neighbouring tissues and metastasize to distant organs, creating serious health hazards. A multitude of factors such as an aging population, unhealthy lifestyle choices like smoking and suboptimal diet, exposure to environmental pollutants, and enhanced detection techniques that allow for early diagnosis are contributing to the rise in cancer cases. MicroRNA is used in conjunction with standard cancer treatments to improve drug responsiveness and elevate patient outcomes. MiRNAs function not only as a means of treatment but also as diagnostic and prognostic biomarkers, aiding in the identification of cancer types, forecasting disease progression, and supervising treatment responses. As an example, the National Cancer Institute, a governmental organization based in the US, disclosed that around 20 million new cases and 9.7 million cancer-related deaths were logged annually in 2022. Projections suggest that by 2040, there will be roughly 15.3 million deaths and 29.9 million new cases annually. As such, the escalating amount of cancer cases are accelerating the expansion of the microRNA market.

What are the key segments defining the microrna market?

The microrna market covered in this report is segmented –

1) By Products: Instruments, Consumables

2) By Assay Type: Immunoassay, Next Generation Sequencing, miRNA Arrays, Polymerase Chain Reaction (PCR) Based Arrays

3) By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications

4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Clinical Research Organizations

Subsegments:

1) By Instruments: Qpcr Systems (Quantitative Pcr), Microarray Platforms, Next-Generation Sequencing (Ngs) Systems, Real-Time Pcr Instruments, Microrna Analyzers

2) By Consumables: Microrna Kits ( Extraction Kits, Detection Kits), Pcr Reagents, Primers And Probes, Microarrays And Chips, Rna Sequencing Kits

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15608&type=smp

Who are the key players steering the development of the microrna market?

Major companies operating in the MicroRNA market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Kaneka Corporation, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Biodynamics Laboratory Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Biogenex Laboratories, Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc., Synlogic Inc., Sistemic Scotland Limited

What are the key trends shaping the future of the microrna market?

Leading firms in the microRNA market are honing in on creating sophisticated solutions like MiRNA probe customization services to cater to the unique requirements of scientists and clinicians, improve miRNA detection precision, and support a broad array of applications. MiRNA probe customization services are specialist services provided by biotech and molecular biology companies to design and generate bespoke probes for individual microRNAs (miRNAs), useful in diverse research and clinical uses. In September 2023, for example, Abnova Corporation, a biotech firm from Taiwan, introduced upgraded customization services for miRNA probes and a new series of cataloged miRNA probes, aimed at satisfying the varying needs of the academic, industrial, and research sections involved in miRNA research. These probes are indispensable in pinpointing and accurately locating miRNAs, small, non-coding RNA molecules vital for different biological processes. Abnova’s customization services promise high precision and low cross-reactivity, making them ideal for analyzing samples with scarce miRNA content.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15608

Which regions are most influential in expanding the microrna market?

North America was the largest region in the microRNA market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the MicroRNA market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Physical Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/physical-therapy-global-market-report

Mycoplasma Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Antiphospholipid Syndrome Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antiphospholipid-syndrome-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theMicroRNA Market?

The surge in cancer incidences is anticipated to significantly boost the microRNA market’s expansion in the future. Cancer constitutes a complicated illness typified by rampant cell growth and proliferation, sometimes resulting in the creation of malignant tumors that can intrude on surrounding tissues and metastasize to far-off organs, thus posing considerable health threats. The uptick in cancer incidences can be attributed to various elements, such as aging demographics, lifestyle decisions like smoking and poor nutrition, environmental toxins, and advanced detection techniques resulting in early diagnosis. MicroRNA is amalgamated with standard cancer treatments to augment drug sensitivity and enhance the final results. Beyond the realm of treatment, miRNAs function as diagnostic and prognostic biomarkers, assisting in classifying different cancer types, forecasting the progression of the disease and tracking treatment responses. For example, as per the National Cancer Institute, a government agency based in the United States, in May 2024, approximately 20 million fresh cases and 9.7 million cancer-related fatalities were annually documented in 2022, and forecasts suggest that by 2040, the figures would escalate to 15.3 million deaths and 29.9 million fresh cases annually. Consequently, the surge in cancer incidences is stimulating the expansion of the microRNA market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15608&type=smp

#What Are the Key Projections for the CAGR of the MicroRNA Market From 2025 to 2034?

The size of the microrna market has seen substantial expansion lately. The market is set to enlarge from $1.33 billion in 2024 to $1.58 billion in 2025, illustrating a compound annual growth rate (CAGR) of 18.9%. This substantial increase during the historic period is primarily due to the inception of microRNAs, RNA interference (RNAi), various genome sequencing initiatives, advances in computational biology and bioinformatics, and an in-depth research on extracellular vehicles (EVs).

Predictions indicate swift expansion for the microrna market in the upcoming years. Its valuation is projected to reach $3.11 billion in 2029, with a compound annual growth rate (CAGR) of 18.5%. The predicted growth within the forecast period can be credited to aspects like clinical translation, regulatory networks, systems biology, microRNA-centric treatments, potential therapeutic applications, and the identification of biomarkers. Top trends projected to dominate during the forecast period include technological progression, bioinformatics, data analysis, conservation across various species, interactions with microbiomes, and operational mechanisms.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15608

What Key Market Trends and Innovations Are Shaping the Future of theMicroRNA Industry?

Key players in the microRNA market are prioritizing the development of innovative solutions such as MiRNA probe customization services with the aim to cater to the particular requirements of researchers and clinicians, improve the precision of miRNA detection, and support a plethora of applications. This refers to unique services provided by biotechnology and molecular biology firms to create and prepare customized probes that correspond to specific microRNAs (miRNAs) for a variety of research and clinical uses. In September 2023, for example, Abnova Corporation, a biotech company based in Taiwan, introduced enhanced miRNA probe customization services, and a fresh series of cataloged miRNA probes, aiming to fulfill the varying requirements of academic, industrial, and miRNA research communities. These probes are critical in recognizing and accurately pinpointing miRNAs, small non-coding RNA molecules that are integral to numerous biological processes. The customization services offered by Abnova guarantee maximum specificity and minimal cross-reactivity, rendering them ideal for the analysis of samples with scarce miRNA content.

Which Companies Are Leading the Charge in Expanding theMicroRNA Market Growth?

Major companies operating in the MicroRNA market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Kaneka Corporation, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Biodynamics Laboratory Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Biogenex Laboratories, Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc., Synlogic Inc., Sistemic Scotland Limited

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/microrna-global-market-report

How is the Global MicroRNA Market Segemented?

The microrna market covered in this report is segmented –

1) By Products: Instruments, Consumables

2) By Assay Type: Immunoassay, Next Generation Sequencing, miRNA Arrays, Polymerase Chain Reaction (PCR) Based Arrays

3) By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications

4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Clinical Research Organizations

Subsegments:

1) By Instruments: Qpcr Systems (Quantitative Pcr), Microarray Platforms, Next-Generation Sequencing (Ngs) Systems, Real-Time Pcr Instruments, Microrna Analyzers

2) By Consumables: Microrna Kits ( Extraction Kits, Detection Kits), Pcr Reagents, Primers And Probes, Microarrays And Chips, Rna Sequencing Kits

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15608&type=smp

Which Geographics are Influencing the Growth of the MicroRNA Market?

North America was the largest region in the microRNA market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the MicroRNA market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global MicroRNA Market 2025, By The Business Research Company:

Physical Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/physical-therapy-global-market-report

Mycoplasma Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Antiphospholipid Syndrome Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antiphospholipid-syndrome-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theMicroRNA Market?

The surge in cancer incidences is anticipated to significantly boost the microRNA market’s expansion in the future. Cancer constitutes a complicated illness typified by rampant cell growth and proliferation, sometimes resulting in the creation of malignant tumors that can intrude on surrounding tissues and metastasize to far-off organs, thus posing considerable health threats. The uptick in cancer incidences can be attributed to various elements, such as aging demographics, lifestyle decisions like smoking and poor nutrition, environmental toxins, and advanced detection techniques resulting in early diagnosis. MicroRNA is amalgamated with standard cancer treatments to augment drug sensitivity and enhance the final results. Beyond the realm of treatment, miRNAs function as diagnostic and prognostic biomarkers, assisting in classifying different cancer types, forecasting the progression of the disease and tracking treatment responses. For example, as per the National Cancer Institute, a government agency based in the United States, in May 2024, approximately 20 million fresh cases and 9.7 million cancer-related fatalities were annually documented in 2022, and forecasts suggest that by 2040, the figures would escalate to 15.3 million deaths and 29.9 million fresh cases annually. Consequently, the surge in cancer incidences is stimulating the expansion of the microRNA market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15608&type=smp

#What Are the Key Projections for the CAGR of the MicroRNA Market From 2025 to 2034?

The size of the microrna market has seen substantial expansion lately. The market is set to enlarge from $1.33 billion in 2024 to $1.58 billion in 2025, illustrating a compound annual growth rate (CAGR) of 18.9%. This substantial increase during the historic period is primarily due to the inception of microRNAs, RNA interference (RNAi), various genome sequencing initiatives, advances in computational biology and bioinformatics, and an in-depth research on extracellular vehicles (EVs).

Predictions indicate swift expansion for the microrna market in the upcoming years. Its valuation is projected to reach $3.11 billion in 2029, with a compound annual growth rate (CAGR) of 18.5%. The predicted growth within the forecast period can be credited to aspects like clinical translation, regulatory networks, systems biology, microRNA-centric treatments, potential therapeutic applications, and the identification of biomarkers. Top trends projected to dominate during the forecast period include technological progression, bioinformatics, data analysis, conservation across various species, interactions with microbiomes, and operational mechanisms.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15608

What Key Market Trends and Innovations Are Shaping the Future of theMicroRNA Industry?

Key players in the microRNA market are prioritizing the development of innovative solutions such as MiRNA probe customization services with the aim to cater to the particular requirements of researchers and clinicians, improve the precision of miRNA detection, and support a plethora of applications. This refers to unique services provided by biotechnology and molecular biology firms to create and prepare customized probes that correspond to specific microRNAs (miRNAs) for a variety of research and clinical uses. In September 2023, for example, Abnova Corporation, a biotech company based in Taiwan, introduced enhanced miRNA probe customization services, and a fresh series of cataloged miRNA probes, aiming to fulfill the varying requirements of academic, industrial, and miRNA research communities. These probes are critical in recognizing and accurately pinpointing miRNAs, small non-coding RNA molecules that are integral to numerous biological processes. The customization services offered by Abnova guarantee maximum specificity and minimal cross-reactivity, rendering them ideal for the analysis of samples with scarce miRNA content.

Which Companies Are Leading the Charge in Expanding theMicroRNA Market Growth?

Major companies operating in the MicroRNA market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Kaneka Corporation, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Biodynamics Laboratory Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Biogenex Laboratories, Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc., Synlogic Inc., Sistemic Scotland Limited

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/microrna-global-market-report

How is the Global MicroRNA Market Segemented?

The microrna market covered in this report is segmented –

1) By Products: Instruments, Consumables

2) By Assay Type: Immunoassay, Next Generation Sequencing, miRNA Arrays, Polymerase Chain Reaction (PCR) Based Arrays

3) By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications

4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Clinical Research Organizations

Subsegments:

1) By Instruments: Qpcr Systems (Quantitative Pcr), Microarray Platforms, Next-Generation Sequencing (Ngs) Systems, Real-Time Pcr Instruments, Microrna Analyzers

2) By Consumables: Microrna Kits ( Extraction Kits, Detection Kits), Pcr Reagents, Primers And Probes, Microarrays And Chips, Rna Sequencing Kits

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15608&type=smp

Which Geographics are Influencing the Growth of the MicroRNA Market?

North America was the largest region in the microRNA market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the MicroRNA market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global MicroRNA Market 2025, By The Business Research Company:

Physical Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/physical-therapy-global-market-report

Mycoplasma Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Antiphospholipid Syndrome Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antiphospholipid-syndrome-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theMicroRNA Market?

The surge in cancer incidences is anticipated to significantly boost the microRNA market’s expansion in the future. Cancer constitutes a complicated illness typified by rampant cell growth and proliferation, sometimes resulting in the creation of malignant tumors that can intrude on surrounding tissues and metastasize to far-off organs, thus posing considerable health threats. The uptick in cancer incidences can be attributed to various elements, such as aging demographics, lifestyle decisions like smoking and poor nutrition, environmental toxins, and advanced detection techniques resulting in early diagnosis. MicroRNA is amalgamated with standard cancer treatments to augment drug sensitivity and enhance the final results. Beyond the realm of treatment, miRNAs function as diagnostic and prognostic biomarkers, assisting in classifying different cancer types, forecasting the progression of the disease and tracking treatment responses. For example, as per the National Cancer Institute, a government agency based in the United States, in May 2024, approximately 20 million fresh cases and 9.7 million cancer-related fatalities were annually documented in 2022, and forecasts suggest that by 2040, the figures would escalate to 15.3 million deaths and 29.9 million fresh cases annually. Consequently, the surge in cancer incidences is stimulating the expansion of the microRNA market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15608&type=smp

#What Are the Key Projections for the CAGR of the MicroRNA Market From 2025 to 2034?

The size of the microrna market has seen substantial expansion lately. The market is set to enlarge from $1.33 billion in 2024 to $1.58 billion in 2025, illustrating a compound annual growth rate (CAGR) of 18.9%. This substantial increase during the historic period is primarily due to the inception of microRNAs, RNA interference (RNAi), various genome sequencing initiatives, advances in computational biology and bioinformatics, and an in-depth research on extracellular vehicles (EVs).

Predictions indicate swift expansion for the microrna market in the upcoming years. Its valuation is projected to reach $3.11 billion in 2029, with a compound annual growth rate (CAGR) of 18.5%. The predicted growth within the forecast period can be credited to aspects like clinical translation, regulatory networks, systems biology, microRNA-centric treatments, potential therapeutic applications, and the identification of biomarkers. Top trends projected to dominate during the forecast period include technological progression, bioinformatics, data analysis, conservation across various species, interactions with microbiomes, and operational mechanisms.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15608

What Key Market Trends and Innovations Are Shaping the Future of theMicroRNA Industry?

Key players in the microRNA market are prioritizing the development of innovative solutions such as MiRNA probe customization services with the aim to cater to the particular requirements of researchers and clinicians, improve the precision of miRNA detection, and support a plethora of applications. This refers to unique services provided by biotechnology and molecular biology firms to create and prepare customized probes that correspond to specific microRNAs (miRNAs) for a variety of research and clinical uses. In September 2023, for example, Abnova Corporation, a biotech company based in Taiwan, introduced enhanced miRNA probe customization services, and a fresh series of cataloged miRNA probes, aiming to fulfill the varying requirements of academic, industrial, and miRNA research communities. These probes are critical in recognizing and accurately pinpointing miRNAs, small non-coding RNA molecules that are integral to numerous biological processes. The customization services offered by Abnova guarantee maximum specificity and minimal cross-reactivity, rendering them ideal for the analysis of samples with scarce miRNA content.

Which Companies Are Leading the Charge in Expanding theMicroRNA Market Growth?

Major companies operating in the MicroRNA market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Kaneka Corporation, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Biodynamics Laboratory Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Biogenex Laboratories, Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc., Synlogic Inc., Sistemic Scotland Limited

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/microrna-global-market-report

How is the Global MicroRNA Market Segemented?

The microrna market covered in this report is segmented –

1) By Products: Instruments, Consumables

2) By Assay Type: Immunoassay, Next Generation Sequencing, miRNA Arrays, Polymerase Chain Reaction (PCR) Based Arrays

3) By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications

4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Clinical Research Organizations

Subsegments:

1) By Instruments: Qpcr Systems (Quantitative Pcr), Microarray Platforms, Next-Generation Sequencing (Ngs) Systems, Real-Time Pcr Instruments, Microrna Analyzers

2) By Consumables: Microrna Kits ( Extraction Kits, Detection Kits), Pcr Reagents, Primers And Probes, Microarrays And Chips, Rna Sequencing Kits

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15608&type=smp

Which Geographics are Influencing the Growth of the MicroRNA Market?

North America was the largest region in the microRNA market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the MicroRNA market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global MicroRNA Market 2025, By The Business Research Company:

Physical Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/physical-therapy-global-market-report

Mycoplasma Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Antiphospholipid Syndrome Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antiphospholipid-syndrome-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theMicroRNA Market?

The surge in cancer incidences is anticipated to significantly boost the microRNA market’s expansion in the future. Cancer constitutes a complicated illness typified by rampant cell growth and proliferation, sometimes resulting in the creation of malignant tumors that can intrude on surrounding tissues and metastasize to far-off organs, thus posing considerable health threats. The uptick in cancer incidences can be attributed to various elements, such as aging demographics, lifestyle decisions like smoking and poor nutrition, environmental toxins, and advanced detection techniques resulting in early diagnosis. MicroRNA is amalgamated with standard cancer treatments to augment drug sensitivity and enhance the final results. Beyond the realm of treatment, miRNAs function as diagnostic and prognostic biomarkers, assisting in classifying different cancer types, forecasting the progression of the disease and tracking treatment responses. For example, as per the National Cancer Institute, a government agency based in the United States, in May 2024, approximately 20 million fresh cases and 9.7 million cancer-related fatalities were annually documented in 2022, and forecasts suggest that by 2040, the figures would escalate to 15.3 million deaths and 29.9 million fresh cases annually. Consequently, the surge in cancer incidences is stimulating the expansion of the microRNA market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15608&type=smp

#What Are the Key Projections for the CAGR of the MicroRNA Market From 2025 to 2034?

The size of the microrna market has seen substantial expansion lately. The market is set to enlarge from $1.33 billion in 2024 to $1.58 billion in 2025, illustrating a compound annual growth rate (CAGR) of 18.9%. This substantial increase during the historic period is primarily due to the inception of microRNAs, RNA interference (RNAi), various genome sequencing initiatives, advances in computational biology and bioinformatics, and an in-depth research on extracellular vehicles (EVs).

Predictions indicate swift expansion for the microrna market in the upcoming years. Its valuation is projected to reach $3.11 billion in 2029, with a compound annual growth rate (CAGR) of 18.5%. The predicted growth within the forecast period can be credited to aspects like clinical translation, regulatory networks, systems biology, microRNA-centric treatments, potential therapeutic applications, and the identification of biomarkers. Top trends projected to dominate during the forecast period include technological progression, bioinformatics, data analysis, conservation across various species, interactions with microbiomes, and operational mechanisms.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15608

What Key Market Trends and Innovations Are Shaping the Future of theMicroRNA Industry?

Key players in the microRNA market are prioritizing the development of innovative solutions such as MiRNA probe customization services with the aim to cater to the particular requirements of researchers and clinicians, improve the precision of miRNA detection, and support a plethora of applications. This refers to unique services provided by biotechnology and molecular biology firms to create and prepare customized probes that correspond to specific microRNAs (miRNAs) for a variety of research and clinical uses. In September 2023, for example, Abnova Corporation, a biotech company based in Taiwan, introduced enhanced miRNA probe customization services, and a fresh series of cataloged miRNA probes, aiming to fulfill the varying requirements of academic, industrial, and miRNA research communities. These probes are critical in recognizing and accurately pinpointing miRNAs, small non-coding RNA molecules that are integral to numerous biological processes. The customization services offered by Abnova guarantee maximum specificity and minimal cross-reactivity, rendering them ideal for the analysis of samples with scarce miRNA content.

Which Companies Are Leading the Charge in Expanding theMicroRNA Market Growth?

Major companies operating in the MicroRNA market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Kaneka Corporation, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Biodynamics Laboratory Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Biogenex Laboratories, Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc., Synlogic Inc., Sistemic Scotland Limited

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/microrna-global-market-report

How is the Global MicroRNA Market Segemented?

The microrna market covered in this report is segmented –

1) By Products: Instruments, Consumables

2) By Assay Type: Immunoassay, Next Generation Sequencing, miRNA Arrays, Polymerase Chain Reaction (PCR) Based Arrays

3) By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications

4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Clinical Research Organizations

Subsegments:

1) By Instruments: Qpcr Systems (Quantitative Pcr), Microarray Platforms, Next-Generation Sequencing (Ngs) Systems, Real-Time Pcr Instruments, Microrna Analyzers

2) By Consumables: Microrna Kits ( Extraction Kits, Detection Kits), Pcr Reagents, Primers And Probes, Microarrays And Chips, Rna Sequencing Kits

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15608&type=smp

Which Geographics are Influencing the Growth of the MicroRNA Market?

North America was the largest region in the microRNA market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the MicroRNA market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global MicroRNA Market 2025, By The Business Research Company:

Physical Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/physical-therapy-global-market-report

Mycoplasma Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Antiphospholipid Syndrome Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antiphospholipid-syndrome-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the microrna market right now?

The scale of the microrna market has seen a significant increase recently, with projections showing it expanding from $1.33 billion in 2024 to $1.58 billion in 2025, maintaining a compound annual growth rate (CAGR) of 18.9%. The growth witnessed in the past years can be traced back to factors such as the discovery of microRNAs, RNA interference (RNAi), genome sequencing efforts, the rise of computational biology and bioinformatics, and research into extracellular vehicles (EVs).

How fast Is the microrna market expected to grow, and what’s its future value?

In the forthcoming years, the microrna market is projected to experience an accelerated growth, reaching $3.11 billion in 2029 with a compound annual growth rate (CAGR) of 18.5%. Clinical translation, regulatory networks, systems biology, microRNA-centered therapeutics, potential therapies, and discovery of biomarkers are factors propelling the growth in this forecast phase. The key trends during this period are likely to involve technological enhancements, bioinformatics, data interpretation, conservation across species, interactions within the microbiome, and operative mechanisms.

Get your microrna market report here!

https://www.thebusinessresearchcompany.com/report/microrna-global-market-report

What are the leading drivers of growth in the microrna market?

The growth of the microRNA market is being fuelled by the rise in cancer incidences. Cancer is a multifaceted disease that is characterized by the unregulated growth and proliferation of cells, which often results in the creation of malignant tumors that can infest neighbouring tissues and metastasize to distant organs, creating serious health hazards. A multitude of factors such as an aging population, unhealthy lifestyle choices like smoking and suboptimal diet, exposure to environmental pollutants, and enhanced detection techniques that allow for early diagnosis are contributing to the rise in cancer cases. MicroRNA is used in conjunction with standard cancer treatments to improve drug responsiveness and elevate patient outcomes. MiRNAs function not only as a means of treatment but also as diagnostic and prognostic biomarkers, aiding in the identification of cancer types, forecasting disease progression, and supervising treatment responses. As an example, the National Cancer Institute, a governmental organization based in the US, disclosed that around 20 million new cases and 9.7 million cancer-related deaths were logged annually in 2022. Projections suggest that by 2040, there will be roughly 15.3 million deaths and 29.9 million new cases annually. As such, the escalating amount of cancer cases are accelerating the expansion of the microRNA market.

What are the key segments defining the microrna market?

The microrna market covered in this report is segmented –

1) By Products: Instruments, Consumables

2) By Assay Type: Immunoassay, Next Generation Sequencing, miRNA Arrays, Polymerase Chain Reaction (PCR) Based Arrays

3) By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications

4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Clinical Research Organizations

Subsegments:

1) By Instruments: Qpcr Systems (Quantitative Pcr), Microarray Platforms, Next-Generation Sequencing (Ngs) Systems, Real-Time Pcr Instruments, Microrna Analyzers

2) By Consumables: Microrna Kits ( Extraction Kits, Detection Kits), Pcr Reagents, Primers And Probes, Microarrays And Chips, Rna Sequencing Kits

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15608&type=smp

Who are the key players steering the development of the microrna market?

Major companies operating in the MicroRNA market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Kaneka Corporation, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Biodynamics Laboratory Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Biogenex Laboratories, Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc., Synlogic Inc., Sistemic Scotland Limited

What are the key trends shaping the future of the microrna market?

Leading firms in the microRNA market are honing in on creating sophisticated solutions like MiRNA probe customization services to cater to the unique requirements of scientists and clinicians, improve miRNA detection precision, and support a broad array of applications. MiRNA probe customization services are specialist services provided by biotech and molecular biology companies to design and generate bespoke probes for individual microRNAs (miRNAs), useful in diverse research and clinical uses. In September 2023, for example, Abnova Corporation, a biotech firm from Taiwan, introduced upgraded customization services for miRNA probes and a new series of cataloged miRNA probes, aimed at satisfying the varying needs of the academic, industrial, and research sections involved in miRNA research. These probes are indispensable in pinpointing and accurately locating miRNAs, small, non-coding RNA molecules vital for different biological processes. Abnova’s customization services promise high precision and low cross-reactivity, making them ideal for analyzing samples with scarce miRNA content.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15608

Which regions are most influential in expanding the microrna market?

North America was the largest region in the microRNA market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the MicroRNA market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Physical Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/physical-therapy-global-market-report

Mycoplasma Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Antiphospholipid Syndrome Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antiphospholipid-syndrome-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the microrna market right now?

The scale of the microrna market has seen a significant increase recently, with projections showing it expanding from $1.33 billion in 2024 to $1.58 billion in 2025, maintaining a compound annual growth rate (CAGR) of 18.9%. The growth witnessed in the past years can be traced back to factors such as the discovery of microRNAs, RNA interference (RNAi), genome sequencing efforts, the rise of computational biology and bioinformatics, and research into extracellular vehicles (EVs).

How fast Is the microrna market expected to grow, and what’s its future value?

In the forthcoming years, the microrna market is projected to experience an accelerated growth, reaching $3.11 billion in 2029 with a compound annual growth rate (CAGR) of 18.5%. Clinical translation, regulatory networks, systems biology, microRNA-centered therapeutics, potential therapies, and discovery of biomarkers are factors propelling the growth in this forecast phase. The key trends during this period are likely to involve technological enhancements, bioinformatics, data interpretation, conservation across species, interactions within the microbiome, and operative mechanisms.

Get your microrna market report here!

https://www.thebusinessresearchcompany.com/report/microrna-global-market-report

What are the leading drivers of growth in the microrna market?

The growth of the microRNA market is being fuelled by the rise in cancer incidences. Cancer is a multifaceted disease that is characterized by the unregulated growth and proliferation of cells, which often results in the creation of malignant tumors that can infest neighbouring tissues and metastasize to distant organs, creating serious health hazards. A multitude of factors such as an aging population, unhealthy lifestyle choices like smoking and suboptimal diet, exposure to environmental pollutants, and enhanced detection techniques that allow for early diagnosis are contributing to the rise in cancer cases. MicroRNA is used in conjunction with standard cancer treatments to improve drug responsiveness and elevate patient outcomes. MiRNAs function not only as a means of treatment but also as diagnostic and prognostic biomarkers, aiding in the identification of cancer types, forecasting disease progression, and supervising treatment responses. As an example, the National Cancer Institute, a governmental organization based in the US, disclosed that around 20 million new cases and 9.7 million cancer-related deaths were logged annually in 2022. Projections suggest that by 2040, there will be roughly 15.3 million deaths and 29.9 million new cases annually. As such, the escalating amount of cancer cases are accelerating the expansion of the microRNA market.

What are the key segments defining the microrna market?

The microrna market covered in this report is segmented –

1) By Products: Instruments, Consumables

2) By Assay Type: Immunoassay, Next Generation Sequencing, miRNA Arrays, Polymerase Chain Reaction (PCR) Based Arrays

3) By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications

4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Clinical Research Organizations

Subsegments:

1) By Instruments: Qpcr Systems (Quantitative Pcr), Microarray Platforms, Next-Generation Sequencing (Ngs) Systems, Real-Time Pcr Instruments, Microrna Analyzers

2) By Consumables: Microrna Kits ( Extraction Kits, Detection Kits), Pcr Reagents, Primers And Probes, Microarrays And Chips, Rna Sequencing Kits

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15608&type=smp

Who are the key players steering the development of the microrna market?

Major companies operating in the MicroRNA market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Kaneka Corporation, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Biodynamics Laboratory Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Biogenex Laboratories, Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc., Synlogic Inc., Sistemic Scotland Limited

What are the key trends shaping the future of the microrna market?

Leading firms in the microRNA market are honing in on creating sophisticated solutions like MiRNA probe customization services to cater to the unique requirements of scientists and clinicians, improve miRNA detection precision, and support a broad array of applications. MiRNA probe customization services are specialist services provided by biotech and molecular biology companies to design and generate bespoke probes for individual microRNAs (miRNAs), useful in diverse research and clinical uses. In September 2023, for example, Abnova Corporation, a biotech firm from Taiwan, introduced upgraded customization services for miRNA probes and a new series of cataloged miRNA probes, aimed at satisfying the varying needs of the academic, industrial, and research sections involved in miRNA research. These probes are indispensable in pinpointing and accurately locating miRNAs, small, non-coding RNA molecules vital for different biological processes. Abnova’s customization services promise high precision and low cross-reactivity, making them ideal for analyzing samples with scarce miRNA content.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15608

Which regions are most influential in expanding the microrna market?

North America was the largest region in the microRNA market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the MicroRNA market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Physical Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/physical-therapy-global-market-report

Mycoplasma Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Antiphospholipid Syndrome Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antiphospholipid-syndrome-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: